Harnessing the Immune System to Fight Cancer

Harnessing the Immune System to Fight Cancer

With the entry of immune checkpoint inhibitors such as anti-PD1 and anti-CTLA-4 into the clinic, excitement about immune-based therapies for cancer has been growing. Three immunologists at the Medical University of South Carolina (MUSC)—Zihai Li, M.D., Ph.D., Shikhar Mehrotra, Ph.D., and Chrystal Paulos, Ph.D.—discuss the promise of immune-based therapies such as immune checkpoint blockade and adoptive cell transfer and how the researchers and clinicians at MUSC are helping advance the field.

More at Progressnotes, MUSC’s Medical Magazine

 


Published

December 15, 2016

Created by

The Medical University of South Carolina

Related Presenters

Zihai Li, MD, PhD

Zihai Li, MD, PhD

Chairman and Professor, Department of Microbiology & Immunology

View full profile

Chrystal Paulos, PhD

Chrystal Paulos, PhD

Associate Professor, Microbiology and Immunology, Surgery

View full profile

Shikhar Mehrotra, PhD

Shikhar Mehrotra, PhD

Associate Director, Cell Therapy Unit, Cell Evaluation & Therapy Shared Resource

View full profile